Cited by 1,403Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record, with a small difference in title or year; 251 of the 252 references it cites were found in a registry or an index.

Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy

Open access

Marian, Ali J., Braunwald, Eugene·2017·Circulation Research

DOI 10.1161/circresaha.117.311059PMC PMC5654557

Open this paper in CoChat — free account

Abstract

Hypertrophic cardiomyopathy (HCM) is a genetic disorder that is characterized by left ventricular hypertrophy unexplained by secondary causes and a nondilated left ventricle with preserved or increased ejection fraction. It is commonly asymmetrical with the most severe hypertrophy involving the basal interventricular septum. Left ventricular outflow tract obstruction is present at rest in about one third of the patients and can be provoked in another third. The histological features of HCM include myocyte hypertrophy and disarray, as well as interstitial fibrosis. The hypertrophy is also frequently associated with left ventricular diastolic dysfunction. In the majority of patients, HCM has a relatively benign course. However, HCM is also an important cause of sudden cardiac death, particularly in adolescents and young adults. Nonsustained ventricular tachycardia, syncope, a family history of sudden cardiac death, and severe cardiac hypertrophy are major risk factors for sudden cardiac death. This complication can usually be averted by implantation of a cardioverter-defibrillator in appropriate high-risk patients. Atrial fibrillation is also a common complication and is not well tolerated. Mutations in over a dozen genes encoding sarcomere-associated proteins cause HCM. MYH7 and MYBPC3 , encoding β-myosin heavy chain and myosin-binding protein C, respectively, are the 2 most common genes involved, together accounting for ≈50% of the HCM families. In ≈40% of HCM patients, the causal genes remain to be identified. Mutations in genes responsible for storage diseases also cause a phenotype resembling HCM (genocopy or phenocopy). The routine applications of genetic testing and preclinical identification of family members represents an important advance. The genetic discoveries have enhanced understanding of the molecular pathogenesis of HCM and have stimulated efforts designed to identify new therapeutic agents.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circresaha.117.311059

Cites

251 of 251 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults
Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T., & Bild, D. E. (1995) · Circulation · doi:10.1161/01.cir.92.4.785 · Cited by 2,274
Sudden Deaths in Young Competitive Athletes
Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009) · Circulation · doi:10.1161/circulationaha.108.804617 · Cited by 2,099
Sudden Death in Young Competitive Athletes: Clinical, Demographic, and Pathological Profiles
Maron, B. J. (1996) · JAMA · doi:10.1001/jama.1996.03540030033028 · Cited by 1,693
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
Semsarian, C., Ingles, J., Maron, M. S., & Maron, B. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.019 · Cited by 1,405
A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation
Geisterfer-Lowrance, A. A. T., Kass, S., Tanigawa, G., Vosberg, H.-P., McKenna, W., Seidman, C. E., & Seidman, J. G. (1990) · Cell · doi:10.1016/0092-8674(90)90274-i · Cited by 1,380
Hypertrophic Cardiomyopathy
Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000066323.15244.54 · Cited by 1,276
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)
O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht439 · Cited by 1,251
Guidelines for investigating causality of sequence variants in human disease
MacArthur, D. G., Manolio, T. A., Dimmock, D. P., Rehm, H. L., Shendure, J., Abecasis, G. R., Adams, D. R., Altman, R. B., Antonarakis, S. E., Ashley, E. A., et al. (2014) · Nature · doi:10.1038/nature13127 · Cited by 1,224
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.
Tiret, L., Rigat, B. A., Visvikis‐Siest, S., Breda, C., Corvol, P. L., Cambien, F., & Soubrier, F. (1992) · Europe PMC (PubMed Central) · Cited by 1,174
Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction
Maron, M. S., Olivotto, I., Zenovich, A. G., Link, M. S., Pandian, N. G., Kuvin, J. T., Nistri, S., Cecchi, F., Udelson, J. E., & Maron, B. J. (2006) · Circulation · doi:10.1161/circulationaha.106.644682 · Cited by 1,127
ASYMMETRICAL HYPERTROPHY OF THE HEART IN YOUNG ADULTS
Teare, D. (1958) · Heart · doi:10.1136/hrt.20.1.1 · Cited by 1,082
α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere
Thierfelder, L., Watkins, H. C., MacRae, C. A., Lamas, R., McKenna, W. J., Vosberg, H.-P., Seidman, J. G., & Seidman, C. E. (1994) · Cell · doi:10.1016/0092-8674(94)90054-x · Cited by 1,034
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliot, P. M., Poloniecki, J. D., Dickie, S., Sharma, S., Monserrat, L., Varnava, A. M., Mahon, N., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 976
Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy
Watkins, H. C., McKenna, W. J., Thierfelder, L., Suk, H. J., Anan, R., O'Donoghue, A., Spirito, P., Matsumori, A., Moravec, C. S., Seidman, J. G., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504203321603 · Cited by 935
A Prospective Study of Sudden Cardiac Death among Children and Young Adults
Bagnall, R. D., Weintraub, R. G., Ingles, J., Duflou, J. A., Yeates, L., Lam, L., Davis, A. M., Thompson, T. N., Connell, V., Wallace, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1510687 · Cited by 847
Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
O’Hanlon, R., Grasso, A. E., Roughton, M., Moon, J., Clark, S., Wage, R., Webb, J., Kulkarni, M., Dawson, D. K., Sulaibeekh, L., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.010 · Cited by 816
Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Maron, B. J., Spirito, P., Shen, W.-K., Haas, T. S., Formisano, F., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Lawrenz, T., et al. (2007) · JAMA · doi:10.1001/jama.298.4.405 · Cited by 802
Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients
D, E. B. M., Lambrew, C. T., Rockoff, S. D., Ross, J., & Morrow, A. G. (1964) · Circulation · doi:10.1161/01.cir.29.5s4.iv-3 · Cited by 758
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy
Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H. C., Chudley, A. E., McKenna, W. J., Kristinsson, A., Roberts, R., Sole, M. J., Maron, B. J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381802 · Cited by 757
Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy
Maron, B. J., Wolfson, J. K., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80181-4 · Cited by 754
Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 745
Characteristics and Prognostic Implications of Myosin Missense Mutations in Familial Hypertrophic Cardiomyopathy
Watkins, H. C., Rosenzweig, A., Hwang, D., Levi, T., McKenna, W. J., Seidman, C. E., & Seidman, J. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204233261703 · Cited by 742
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples
Walsh, R., Thomson, K. L., Ware, J. S., Funke, B., Woodley, J., McGuire, K., Mazzarotto, F., Blair, E. M., Seller, A., Taylor, J. C., et al. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.90 · Cited by 735
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432304 · Cited by 720
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
Green, E. M., Wakimoto, H., Anderson, R. L., Evanchik, M. J., Gorham, J., Harrison, B. C., Henze, M., Kawas, R. F., Oslob, J. D., Rodrı́guez, H. M., et al. (2016) · Science · doi:10.1126/science.aad3456 · Cited by 708
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Ho, C. Y., López, B., Coelho‐Filho, O. R., Lakdawala, N. K., Cirino, A. L., Jarolı́m, P., Kwong, R. Y. K., González, A., Colan, S. D., Seidman, J. G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002659 · Cited by 697
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells
Lan, F., Lee, A. S., Liang, P., Sanchez-Freire, V., Nguyen, P. K., Wang, L., Han, L., Yen, M., Wang, Y., Sun, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.10.010 · Cited by 667
Hypertrophic Cardiomyopathy
Maron, B. J., Ommen, S. R., Semsarian, C., Spirito, P., Olivotto, I., & Maron, M. S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.003 · Cited by 652
Expression of the cardiac ventricular alpha- and beta-myosin heavy chain genes is developmentally and hormonally regulated.
Lompré, A., Nadal-Ginard, B., & Mahdavi, V. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82162-0 · Cited by 615
Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of Hypertrophy
Nagueh, S. F., Bachinski, L. L., Meyer, D., Hill, R., Zoghbi, W. A., Tam, J. W., Quiñones, M. A., Roberts, R., & Marian, A. J. (2001) · Circulation · doi:10.1161/01.cir.104.2.128 · Cited by 615
Self-citation
An mRNA Surveillance Mechanism That Eliminates Transcripts Lacking Termination Codons
Frischmeyer, P. A., van Hoof, A., O’Donnell, K. A., Guerrerio, A. L., Parker, R., & Dietz, H. C. (2002) · Science · doi:10.1126/science.1067338 · Cited by 583
Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle
Poetter, K., Jiang, H., Hassanzadeh, S., Master, S. R., Chang, A., Dalakas, M. C., Rayment, I., Sellers, J. R., Fananapazir, L., & Epstein, N. D. (1996) · Nature Genetics · doi:10.1038/ng0596-63 · Cited by 582
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-379 · Cited by 576
Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy
Sachdev, B., Takenaka, T., Teraguchi, H., Tei, C., Lee, P., McKenna, W. J., & Elliot, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000012626.81324.38 · Cited by 569
A Mouse Model of Familial Hypertrophic Cardiomyopathy
Geisterfer-Lowrance, A. A. T., Christe, M. E., Conner, D. A., Ingwall, J. S., Schöen, F. J., Seidman, C. E., & Seidman, J. G. (1996) · Science · doi:10.1126/science.272.5262.731 · Cited by 554
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy
Monserrat, L., Elliott, P. M., Gimeno, J. R., Sharma, S., Penas-Lado, M., & McKenna, W. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00827-1 · Cited by 541
Myosin heavy chain isoform expression in the failing and nonfailing human heart
Miyata, S., Minobe, W., Bristow, M. R., & Leinwand, L. A. (2000) · Circulation Research · doi:10.1161/01.res.86.4.386 · Cited by 538
Asymmetric Septal Hypertrophy
Henry, W. L., Clark, C. E., & Epstein, S. E. (1973) · Circulation · doi:10.1161/01.cir.47.2.225 · Cited by 520
Long-term outcome in patients with apical hypertrophic cardiomyopathy
Eriksson, M. J., Sonnenberg, B., Woo, A., Rakowski, P., Parker, T. G., Wigle, E. D., & Rakowski, H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01778-8 · Cited by 476
Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
Teekakirikul, P., Eminaga, S., Toka, O., Alcalai, R., Wang, L., Wakimoto, H., Nayor, M. G., Konno, T., Gorham, J., Wolf, C. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42028 · Cited by 456
Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Harrigan, C. J., Appelbaum, E. A., Gibson, C. M., Lesser, J. R., Haas, T. S., Udelson, J. E., Manning, W. J., & Maron, B. J. (2011) · Circulation · doi:10.1161/circulationaha.110.985812 · Cited by 448
Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy
Crilley, J. G., Boehm, E. A., Blair, E. M., Rajagopalan, B., Blamire, A. M., Styles, P., McKenna, W. J., Östman‐Smith, I., Clarke, K., & Watkins, H. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)03009-7 · Cited by 437
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy
Driest, S. L. V., Vasile, V. C., Ommen, S. R., Will, M. L., Tajik, A. J., Gersh, B. J., & Ackerman, M. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.045 · Cited by 423
Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity
Alfares, A. A., Kelly, M. A., McDermott, G., Funke, B. H., Lebo, M. S., Baxter, S. B., Shen, J., McLaughlin, H. M., Clark, E. H., Babb, L. J., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.205 · Cited by 412
Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death
Marian, A. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)92064-z · Cited by 411
Self-citation
Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy
Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.012 · Cited by 410 · cited 1×
“Disopyramide, a negative inotropic agent, when added to a β-blocker may reduce symptoms further in patients with LVOT obstruction.(231) L-type calcium channel blockers, such as verapamil or diltiazem, may be beneficial in patients who do not tolerate or respond to β-blockers.”
Background
Long-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry Disease
Wilcox, W. R., for the International Fabry Disease Study Group, Banikazemi, M., Guffon, N., Waldek, S., Lee, P., Linthorst, G. E., Desnick, R. J., & Germain, D. P. (2004) · The American Journal of Human Genetics · doi:10.1086/422366 · Cited by 401
α-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy
Mogensen, J., Klausen, I. C., Pedersen, A. K., Egeblad, H., Bross, P., Kruse, T. A., Gregersen, N., HANSEN, P. S., Baandrup, U. T., & Børglum, A. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6460 · Cited by 396
Angiotensin II Blockade Reverses Myocardial Fibrosis in a Transgenic Mouse Model of Human Hypertrophic Cardiomyopathy
Lim, D., Lutucuta, S., Bachireddy, P., Youker, K. A., Evans, A. J., Entman, M. L., Roberts, R., & Marian, A. J. (2001) · Circulation · doi:10.1161/01.cir.103.6.789 · Cited by 387
Self-citation
Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling
Ingles, J., Doolan, A., Chiu, C., Seidman, J. G., Seidman, C. E., & Semsarian, C. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.033886 · Cited by 385
Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly
Niimura, H., Patton, K. K., McKenna, W. J., Soults, J., Maron, B. J., Seidman, J. G., & Seidman, C. E. (2002) · Circulation · doi:10.1161/hc0402.102990 · Cited by 363
Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review
Guttmann, O. P., Rahman, M. S., O’Mahony, C., Anastasakis, A., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2013-304276 · Cited by 357
Myosin isoenzymic distribution correlates with speed of myocardial contraction
Schwartz, K. (1981) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(81)90297-2 · Cited by 353
Simvastatin Induces Regression of Cardiac Hypertrophy and Fibrosis and Improves Cardiac Function in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy
Patel, R., Nagueh, S. F., Tsybouleva, N., Abdellatif, M., Lutucuta, S., Kopelen, H. A., Quiñones, M. A., Zoghbi, W. A., Entman, M. L., Roberts, R., et al. (2001) · Circulation · doi:10.1161/hc2801.094031 · Cited by 353
Self-citation
Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles
Reiser, P. J., Portman, M. A., Ning, X.-H., & Moravec, C. S. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1814 · Cited by 351
Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy
Roncarati, R., Anselmi, C. V., Losi, M. A., Papa, L., Cavarretta, E., Martins, P. A. D. C., Contaldi, C., Jotti, G. S., Franzone, A., Galastri, L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.041 · Cited by 329
Cardiac Myosin-Binding Protein C Mutations and Hypertrophic Cardiomyopathy
van Dijk, S. J., Dooijes, D., dos Remedios, C. G., Michels, M., Lamers, J. M. J., Winegrad, S., Schlossarek, S., Carrier, L., ten Cate, F. J., Stienen, G. J. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.838672 · Cited by 328
Comparison of Electrocardiographic Criteria for the Detection of Cardiac Abnormalities in Elite Black and White Athletes
Sheikh, N., Papadakis, M., Ghani, S., Zaidi, A., Gati, S., Adami, P. E., Carré, F., Schnell, F., Wilson, M. G., Ávila, P., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006179 · Cited by 326
Structural Analysis of the Titin Gene in Hypertrophic Cardiomyopathy: Identification of a Novel Disease Gene
Satoh, M., Takahashi, M., Sakamoto, T., Hiroe, M., Marumo, F., & Kimura, A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1221 · Cited by 325
Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
Maron, B. J., Rowin, E. J., Casey, S. A., Link, M. S., Lesser, J. R., Chan, R. H. M., Garberich, R. F., Udelson, J. E., & Maron, M. S. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.061 · Cited by 317
Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations
Mogensen, J., Kubo, T., Duque, M., Uribe, W., Shaw, A., Murphy, R. T., Gimeno, J. R., Elliot, P. M., & McKenna, W. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16336 · Cited by 313
Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis).
Brock, R. (1957) · PubMed · Cited by 309
Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy
Hayashi, T., Arimura, T., Satoh, M., Ueda, K., Hohda, S., Inagaki, N., Takahashi, M., Hori, H., Yasunami, M., Nishi, H., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.08.058 · Cited by 302
Organization and Sequence of Human Cardiac Myosin Binding Protein C Gene (MYBPC3) and Identification of Mutations Predicted to Produce Truncated Proteins in Familial Hypertrophic Cardiomyopathy
Carrier, L., Bonne, G., Bährend, E., Yu, B., Richard, P., Niel, F., Hainque, B., Cruaud, C., Gary, F., Labeit, S., et al. (1997) · Circulation Research · doi:10.1161/01.res.0000435859.24609.b3 · Cited by 301
Hypertrophic Cardiomyopathy
Varnava, A. M., Elliot, P. M., BABOONIAN, C., Davison, F. D., Davies, M. J., & McKenna, W. J. (2001) · Circulation · doi:10.1161/hc3701.095952 · Cited by 298
Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults
Zou, Y., Song, L., Wang, Z., Ma, A., Liu, T., Gu, H., Lu, S., Peng-zhu, W., Zhang, †. Y., Shen, †. L., et al. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.05.009 · Cited by 296
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
Girolami, F., Ho, C. Y., Semsarian, C., Baldi, M., Will, M. L., Baldini, K., Torricelli, F., Yeates, L., Cecchi, F., Ackerman, M. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.062 · Cited by 295
Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine
Popp, M. W., & Maquat, L. E. (2016) · Cell · doi:10.1016/j.cell.2016.05.053 · Cited by 293
Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy
Maron, B. J., Spirito, P., Ackerman, M. J., Casey, S. A., Semsarian, C., Estes, N. A. M., Shannon, K. M., Ashley, E. A., Day, S. M., Pacileo, G., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.037 · Cited by 288
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
Siontis, K. C., Geske, J. B., Ong, K., Nishimura, R. A., Ommen, S. R., & Gersh, B. J. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001002 · Cited by 276
Tissue Doppler Imaging Predicts the Development of Hypertrophic Cardiomyopathy in Subjects With Subclinical Disease
Nagueh, S. F., McFalls, J., Meyer, D., Hill, R., Zoghbi, W. A., Tam, J. W., Quiñones, M. A., Roberts, R., & Marian, A. J. (2003) · Circulation · doi:10.1161/01.cir.0000084500.72232.8d · Cited by 275
Self-citation
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy
Adabag, A. S., Casey, S. A., Kuskowski, M. A., Zenovich, A. G., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.043 · Cited by 273
Prevalence of Fabry Disease in Female Patients With Late-Onset Hypertrophic Cardiomyopathy
Chimenti, C., Pieroni, M., Morgante, E., Antuzzi, D., Russo, A., Russo, M. A., Maseri, A., & Frustaci, A. (2004) · Circulation · doi:10.1161/01.cir.0000139847.74101.03 · Cited by 269
Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy
Shah, J., Esteban, M. T. T., Thaman, R., Sharma, R., Mist, B., Pantazis, A. A., Ward, D., Kohli, S. K., Page, S. P., Demetrescu, C. D., et al. (2007) · Heart · doi:10.1136/hrt.2007.126003 · Cited by 257
A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy
Davis, J., Davis, L. C., Correll, R. N., Makarewich, C. A., Schwanekamp, J. A., Moussavi‐Harami, F., Wang, D., York, A. J., Wu, H., Houser, S. R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.002 · Cited by 249
α-Myosin Heavy Chain
Carniel, E., Taylor, M. R. G., Sinagra, G., Lenarda, A. D., Ku, L., Fain, P. R., Boucek, M. M., Cavanaugh, J. L., Miočiċ, S., Slavov, D. B., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.507699 · Cited by 248
Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage
Schelbert, E. B., Piehler, K. M., Zaręba, K. M., Moon, J., Ugander, M., Messroghli, D., Valeti, U. S., Chang, C. H., Shroff, S. G., Dı́ez, J., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002613 · Cited by 241
Effects of Beta Adrenergic Blockade on the Circulation, with Particular Reference to Observations in Patients with Hypertrophic Subaortic Stenosis
Harrison, D. C., D, E. B. M., Glick, G., Mason, D. T., Chidsey, C. A., & Ross, J. (1964) · Circulation · doi:10.1161/01.cir.29.1.84 · Cited by 239
Genetic advances in sarcomeric cardiomyopathies: state of the art
Ho, C. Y., Charron, P., Richard, P., Girolami, F., van Spaendonck‐Zwarts, K. Y., & Pinto, Y. M. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv025 · Cited by 239
Evidence From Human Myectomy Samples That MYBPC3 Mutations Cause Hypertrophic Cardiomyopathy Through Haploinsufficiency
Marston, S. B., Copeland, O., Jacques, A. M., Livesey, K., Tsang, V. T., McKenna, W. J., Jalilzadeh, S., Carballo, S., Redwood, C. S., & Watkins, H. C. (2009) · Circulation Research · doi:10.1161/circresaha.109.202440 · Cited by 238
Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy
Marian, A. J. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06187-5 · Cited by 235
Self-citation
Aldosterone, Through Novel Signaling Proteins, Is a Fundamental Molecular Bridge Between the Genetic Defect and the Cardiac Phenotype of Hypertrophic Cardiomyopathy
Tsybouleva, N., Zhang, L., Chen, S., Patel, R. T., Lutucuta, S., Nemoto, S., DeFreitas, G., Entman, M. L., Carabello, B. A., Roberts, R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000121426.43044.2b · Cited by 234
Self-citation
Allele-Specific Silencing of Mutant Myh6 Transcripts in Mice Suppresses Hypertrophic Cardiomyopathy
Jiang, J., Wakimoto, H., Seidman, J. G., & Seidman, C. E. (2013) · Science · doi:10.1126/science.1236921 · Cited by 230
An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy
Fatkin, D., McConnell, B. K., Mudd, J. O., Semsarian, C., Moskowitz, I. P. G., Schöen, F. J., Giewat, M., Seidman, C. E., & Seidman, J. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11093 · Cited by 228
Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
Lu, F. Y., Ellims, A., Moore, X., White, D. A., Taylor, A. J., Chin-Dusting, J. P. F., & Dart, A. M. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0672-0 · Cited by 226
Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy
Erdmann, J., Dähmlow, S., Wischke, S., Senyuva, M., Werner, U., Raible, J., Tanis, N., Dyachenko, S., Hummel, M. W., Hetzer, R., et al. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00151.x · Cited by 225
Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs∗
D, E. B. M., & Ebert, P. A. (1962) · The American Journal of Cardiology · doi:10.1016/0002-9149(62)90373-9 · Cited by 217
Prevalence of Sarcomere Protein Gene Mutations in Preadolescent Children With Hypertrophic Cardiomyopathy
Kaski, J. P., Syrris, P., Tome, M., Jenkins, S. A., Pantazis, A. A., Deanfield, J. E., McKenna, W. J., & Elliot, P. M. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.821314 · Cited by 217
Hereditary cardiovascular dysplasia
Paré, J. A. P., Fraser, R. G., Pirozynski, W. J., Shanks, J. A., & Stubington, D. (1961) · The American Journal of Medicine · doi:10.1016/0002-9343(61)90222-4 · Cited by 215
Overexpression of Transforming Growth Factor-β1 and Insulin-Like Growth Factor-I in Patients With Idiopathic Hypertrophic Cardiomyopathy
Li, R., Li, G., Mickle, D. A. G., Weisel, R. D., Merante, F., Lüss, H., Rao, V., Christakis, G. T., & Williams, W. G. (1997) · Circulation · doi:10.1161/01.cir.96.3.874 · Cited by 211
Angiotensin-I Converting Enzyme Genotypes and Left Ventricular Hypertrophy in Patients With Hypertrophic Cardiomyopathy
Lechin, M. E., Quiñones, M. A., Omran, A., Hill, R., Yu, Q., Rakowski, H., Wigle, D., Liew, C. C., Sole, M. J., Roberts, R., et al. (1995) · Circulation · doi:10.1161/01.cir.92.7.1808 · Cited by 210
Self-citation
Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy
Maron, M. S., Rowin, E. J., Olivotto, I., Casey, S. A., Arretini, A., Tomberli, B., Garberich, R., Link, M. S., Chan, R. H. M., Lesser, J. R., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.01.023 · Cited by 209
Altered myosin isozyme patterns from pressure-overloaded and thyrotoxic hypertrophied rabbit hearts.
Litten, R. Z., Martin, B. J., Low, R. B., & Alpert, N. R. (1982) · Circulation Research · doi:10.1161/01.res.50.6.856 · Cited by 207
Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry Disease Survey
Elliot, P. M., Baker, R. J., Pasquale, F., Quarta, G., Ebrahim, H. Y., Mehta, A. B., & Hughes, D. A. (2011) · Heart · doi:10.1136/heartjnl-2011-300364 · Cited by 207
Myocardial Collagen Turnover in Hypertrophic Cardiomyopathy
Lombardi, R., Betocchi, S., Losi, M. A., Tocchetti, C. G., Aversa, M., Miranda, M., D’Alessandro, G., Cacace, A., Ciampi, Q., & Massimo Chiariello, A. (2003) · Circulation · doi:10.1161/01.cir.0000090687.97972.10 · Cited by 205
Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes
Walsh, R., Buchan, R. J., Wilk, A., John, S., Felkin, L. E., Thomson, K. L., Tang, H. C., Chin, C., Pua, C. J., Raphael, C. E., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw603 · Cited by 205
A systematic review and meta-analysis of genotype–phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations
Lopes, L. R., Rahman, M. S., & Elliot, P. M. (2013) · Heart · doi:10.1136/heartjnl-2013-303939 · Cited by 204
Perturbed Length-Dependent Activation in Human Hypertrophic Cardiomyopathy With Missense Sarcomeric Gene Mutations
Sequeira, V., Wijnker, P. J. M., Nijenkamp, L. L. A. M., Kuster, D. W. D., Najafi, A., Witjas‐Paalberends, E. R., Regan, J. A., Boontje, N. M., ten Cate, F. J., Germans, T., et al. (2013) · Circulation Research · doi:10.1161/circresaha.111.300436 · Cited by 196
Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation
Debonnaire, P., Joyce, E., Hiemstra, Y. L., Mertens, B. J. A., Atsma, D. E., Schalij, M. J., Bax, J. J., Delgado, V., & Marsan, N. A. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004052 · Cited by 195
Myozenin 2 Is a Novel Gene for Human Hypertrophic Cardiomyopathy
Osio, A., Tan, L., Chen, S. N., Lombardi, R., Nagueh, S. F., Shete, S. S., Roberts, R., Willerson, J. T., & Marian, A. J. (2007) · Circulation Research · doi:10.1161/01.res.0000263008.66799.aa · Cited by 194
Self-citation
A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.
Tardiff, J. C., Factor, S. M., Tompkins, B., Hewett, T. E., Palmer, B. M., Moore, R. L., Schwartz, S. D., Robbins, J. M., & Leinwand, L. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2389 · Cited by 193
Differentiating Left Ventricular Hypertrophy in Athletes from That in Patients With Hypertrophic Cardiomyopathy
Caselli, S., Maron, M. S., Urbano-Moral, J. Á., Pandian, N. G., Maron, B. J., & Pelliccia, A. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.070 · Cited by 191
Functional Aortic Stenosis
Morrow, A. G., & D, E. B. M. (1959) · Circulation · doi:10.1161/01.cir.20.2.181 · Cited by 188
Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans
Landstrom, A. P., Weisleder, N. L., Batalden, K. B., Bos, J. M., Tester, D. J., Ommen, S. R., Wehrens, X. H. T., Claycomb, W. C., Ko, J., Hwang, M., et al. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.04.006 · Cited by 182
Hypertrophic Obstructive Cardiomyopathy
Nishimura, R. A., Seggewiß, H., & Schaff, H. V. (2017) · Circulation Research · doi:10.1161/circresaha.116.309348 · Cited by 182
Regional heterogeneity of function in hypertrophic cardiomyopathy.
Kramer, C. M., Reichek, N., Ferrari, V. A., Theobald, T. M., Dawson, J., & Axel, L. (1994) · Circulation · doi:10.1161/01.cir.90.1.186 · Cited by 181
Understanding Cardiomyopathy Phenotypes Based on the Functional Impact of Mutations in the Myosin Motor
Moore, J. R., Leinwand, L. A., & Warshaw, D. M. (2012) · Circulation Research · doi:10.1161/circresaha.110.223842 · Cited by 181
A transgenic rabbit model for human hypertrophic cardiomyopathy
Marian, A. J., Wu, Y., Lim, D.-S., McCluggage, M., Youker, K., Yu, Q.-T., Brugada, R., DeMayo, F., Quinones, M., & Roberts, R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7956 · Cited by 181
Self-citation
Impaired Rate of Left Ventricular Filling in Idiopathic Hypertrophic Subaortic Stenosis and Valvular Aortic Stenosis
STEWART, S., Mason, D. T., & D, E. B. M. (1968) · Circulation · doi:10.1161/01.cir.37.1.8 · Cited by 179
Risk of Death in Long-Term Follow-Up of Patients With Apical Hypertrophic Cardiomyopathy
Klarich, K. W., Jost, C. H. A., Binder, J. S., Connolly, H. M., Scott, C. G., Freeman, W. K., Ackerman, M. J., Nishimura, R. A., Tajik, A. J., & Ommen, S. R. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.02.040 · Cited by 179
Hypertrophic cardiomyopathy — pathology and pathogenesis
Davies, M. J., & McKenna, W. J. (1995) · Histopathology · doi:10.1111/j.1365-2559.1995.tb00267.x · Cited by 178
Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers
Christiaans, I., van Engelen, K., van Langen, I. M., Birnie, E., Bonsel, G. J., Elliott, P. M., & Wilde, A. A. M. (2010) · EP Europace · doi:10.1093/europace/eup431 · Cited by 176
Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated With Thin-Filament Gene Mutations
Coppini, R., Ho, C. Y., Ashley, E. A., Day, S. M., Ferrantini, C., Girolami, F., Tomberli, B., Bardi, S., Torricelli, F., Cecchi, F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.059 · Cited by 175
Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy
Geier, C., Gehmlich, K., Ehler, E., Haßfeld, S., Perrot, A., Hayeß, K., Cardim, N. M., Wenzel, K., Erdmann, B., Krackhardt, F., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn160 · Cited by 174
Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice
Mearini, G., Stimpel, D., Geertz, B., Weinberger, F., Krämer, E., Schlossarek, S., Mourot-Filiatre, J., Stoehr, A., Dutsch, A., Wijnker, P. J. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms6515 · Cited by 172
Diagnostic Value of Electrocardiography and Echocardiography for Familial Hypertrophic Cardiomyopathy in a Genotyped Adult Population
Charron, P., Dubourg, O., Desnos, M., Isnard, R., Hagège, A. A., Millaire, A., Carrier, L., Bonne, G., Tesson, F., Richard, P., et al. (1997) · Circulation · doi:10.1161/01.cir.96.1.214 · Cited by 172
Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
Maron, B. J., Rowin, E. J., Casey, S. A., Lesser, J. R., Garberich, R., McGriff, D. M., & Maron, M. S. (2015) · Circulation · doi:10.1161/circulationaha.115.017633 · Cited by 172
Investigation of Global and Regional Myocardial Mechanics With 3-Dimensional Speckle Tracking Echocardiography and Relations to Hypertrophy and Fibrosis in Hypertrophic Cardiomyopathy
Urbano-Moral, J. Á., Rowin, E. J., Maron, M. S., Crean, A. M., & Pandian, N. G. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.000842 · Cited by 169
Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy
Kuusisto, J., Kärjä, V. J., Sipola, P., Kholová, I., PEUHKURINEN, K. J., Jääskeläinen, P., Naukkarinen, A., Ylä‐Herttuala, S., Punnonen, K. R. A., & Laakso, M. (2012) · Heart · doi:10.1136/heartjnl-2011-300960 · Cited by 168
Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein.
Rottbauer, W., Gautel, M., Zehelein, J., Labeit, S., Franz, W. M., Fischer, C., Vollrath, B., Mall, G., Dietz, R., Kübler, W., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119555 · Cited by 167
Prediction of Thrombo-Embolic Risk in Patients with Hypertrophic Cardiomyopathy (HCM Risk-CVA)
Guttmann, O. P., Pavlou, M., O’Mahony, C., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., García‐Pavía, P., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.316 · Cited by 165
Prevalence of hypertrophic cardiomyopathy in a population of adult japanese workers as detected by echocardiographic screening
Hada, Y., Sakamoto, T., Amano, K., Yamaguchi, T., Takenaka, K., Takahashi, H., Takikawa, R., Hasegawa, I., Takahashi, T., Suzuki, J., et al. (1987) · The American Journal of Cardiology · doi:10.1016/s0002-9149(87)80107-8 · Cited by 164
Diltiazem Treatment for Pre-Clinical Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers
Ho, C. Y., Lakdawala, N. K., Cirino, A. L., Lipshultz, S. E., Sparks, E. A., Abbasi, S. A., Kwong, R. Y. K., Antman, E. M., Semsarian, C., González, A., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.08.003 · Cited by 162
Double or compound sarcomere mutations in hypertrophic cardiomyopathy: A potential link to sudden death in the absence of conventional risk factors
Maron, B. J., Maron, M. S., & Semsarian, C. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.08.009 · Cited by 160
Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy
Hayashi, T., Arimura, T., Ueda, K., Shibata, H., Hohda, S., Takahashi, M., Hori, H., Koga, Y., Oka, N., Imaizumi, T., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.101 · Cited by 159
Prevention of Cardiac Hypertrophy by Atorvastatin in a Transgenic Rabbit Model of Human Hypertrophic Cardiomyopathy
Senthil, V., Chen, S. N., Tsybouleva, N., Halder, T., Nagueh, S. F., Willerson, J. T., Roberts, R., & Marian, A. J. (2005) · Circulation Research · doi:10.1161/01.res.0000177090.07296.ac · Cited by 159
Self-citation
Impairment of the ubiquitin?proteasome system by truncated cardiac myosin binding protein C mutants
Sarikas, A., Carrier, L., Schenke, C., Doll, D., Flavigny, J., Lindenberg, K. S., Thomas Eschenhagen, A., & Zolk, O. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.004 · Cited by 155
Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis
Briasoulis, Α., Mallikethi‐Reddy, S., Palla, M., Alesh, I. G., & Afonso, L. (2015) · Heart · doi:10.1136/heartjnl-2015-307682 · Cited by 150
Cardiac Myosin Binding Protein-C Mutations in Families With Hypertrophic Cardiomyopathy
Page, S. P., Kounas, S. P., Syrris, P., Christiansen, M., Frank-Hansen, R., Andersen, P. S., Elliot, P. M., & McKenna, W. J. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.960831 · Cited by 147
Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse α-cardiac myosin in the laser trap assay
Debold, E. P., Schmitt, J. P., Patlak, J. B., Beck, S., Moore, J. R., Seidman, J. G., Seidman, C. E., & Warshaw, D. M. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00128.2007 · Cited by 147
Human Molecular Genetic and Functional Studies Identify TRIM63 , Encoding Muscle RING Finger Protein 1, as a Novel Gene for Human Hypertrophic Cardiomyopathy
Chen, S. N., Czernuszewicz, G. Z., Tan, Y., Lombardi, R., Jin, J., Willerson, J. T., & Marian, A. J. (2012) · Circulation Research · doi:10.1161/circresaha.112.270207 · Cited by 145
Self-citation
Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy
Millat, G., Bouvagnet, P., Chevalier, P., Dauphin, C., Simon Jouk, P., Da Costa, A., Prieur, F., Bresson, J.-L., Faivre, L., Eicher, J.-C., et al. (2010) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2010.07.007 · Cited by 142
Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities11Each of the authors contributed significantly to the submitted work including: 1) conception and design of the project and/or interpretation of data; 2) drafting and/or revising the manuscript, and 3) final approval of the submitted manuscript.
Maron, B. J., Mathenge, R., Casey, S. A., Poliac, L. C., & Longe, T. F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00039-x · Cited by 141
Muscular Subaortic Stenosis
Flamm, M. D., Harrison, D. C., & Hancock, E. W. (1968) · Circulation · doi:10.1161/01.cir.38.5.846 · Cited by 141
Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice
Fraysse, B., Weinberger, F., Bardswell, S. C., Cuello, F., Vignier, N., Geertz, B., Starbatty, J., Krämer, E., Coirault, C., Thomas Eschenhagen, A., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.009 · Cited by 140
Sudden cardiac death in hypertrophic cardiomyopathy
Marian, A. J., Mares, A., Kelly, D. P., Yu, Q., Abchee, A., Hill, R., & Roberts, R. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060920 · Cited by 139
Self-citation
Effects of Losartan on Left Ventricular Hypertrophy and Fibrosis in Patients With Nonobstructive Hypertrophic Cardiomyopathy
Shimada, Y. J., Passeri, J. J., Baggish, A. L., O’Callaghan, C., Lowry, P. A., Yannekis, G., Abbara, S., Ghoshhajra, B. B., Rothman, R. D., Ho, C. Y., et al. (2013) · JACC Heart Failure · doi:10.1016/j.jchf.2013.09.001 · Cited by 139
The Circulatory Response of Patients with Idiopathic Hypertrophic Subaortic Stenosis to Nitroglycerin and to the Valsalva Maneuver
D, E. B. M., Oldham, H. N., Ross, J., Linhart, J. W., Mason, D. T., & Fort, L. (1964) · Circulation · doi:10.1161/01.cir.29.3.422 · Cited by 137
Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action.
Watkins, H. C., Seidman, C. E., Seidman, J. G., Feng, H., & Sweeney, H. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119063 · Cited by 136
Differentiation of Athlete's Heart from Pathological Forms of Cardiac Hypertrophy by Means of Geometric Indices Derived from Cardiovascular Magnetic Resonance
Petersen, S. E., Selvanayagam, J. B., Francis, J. M., Myerson, S. G., Wiesmann, F., Robson, M. D., Östman‐Smith, I., Casadei, B., Watkins, H. C., & Neubauer, S. (2005) · Journal of Cardiovascular Magnetic Resonance · doi:10.1081/jcmr-200060631 · Cited by 135
Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C
Landstrom, A. P., Parvatiyar, M. S., Pinto, J. R., Marquardt, M. L., Bos, J. M., Tester, D. J., Ommen, S. R., Potter, J. D., & Ackerman, M. J. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.05.003 · Cited by 134
Cardiomyopathies in Noonan syndrome and the other RASopathies
Gelb, B. D., Roberts, A. E., & Tartaglia, M. (2015) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2015.01.002 · Cited by 134
Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study
Maron, B. J., Peterson, E. E., Maron, M. S., & Peterson, J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90337-9 · Cited by 133
Update on hypertrophic cardiomyopathy and a guide to the guidelines
Sen‐Chowdhry, S., Jacoby, D. L., Moon, J., & McKenna, W. J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.140 · Cited by 133
Risk of Sudden Death and Outcome in Patients With Hypertrophic Cardiomyopathy With Benign Presentation and Without Risk Factors
Spirito, P., Autore, C., Formisano, F., Assenza, G. E., Biagini, E., Haas, T. S., Bongioanni, S., Semsarian, C., Devoto, E., Musumeci, B., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.01.435 · Cited by 131
Burden of Rare Sarcomere Gene Variants in the Framingham and Jackson Heart Study Cohorts
Bick, A. G., Flannick, J. A., Ito, K., Cheng, S. C., Vasan, R. S., Parfenov, M. G., Herman, D. S., DePalma, S. R., Gupta, N., Gabriel, S., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.07.017 · Cited by 130
Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations
Witjas‐Paalberends, E. R., Güçlü, A., Germans, T., Knaapen, P., Harms, H. J., Vermeer, A. M. C., Christiaans, I., Wilde, A. A. M., dos Remedios, C. G., Lammertsma, A. A., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu127 · Cited by 130
Cardiac -myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies
Hoedemaekers, Y. M., Çalişkan, K., Majoor‐Krakauer, D. F., van de Laar, I. M. B. H., Michels, M., Witsenburg, M., ten Cate, F. J., Simoons, M. L., & Dooijes, D. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm429 · Cited by 128
Clinical Features of Hypertrophic Cardiomyopathy Caused by Mutation of a “Hot Spot” in the Alpha-Tropomyosin Gene
Coviello, D. A., Maron, B. J., Spirito, P., Watkins, H. C., Vosberg, H.-P., Thierfelder, L., Schöen, F. J., Seidman, J. G., & Seidman, C. E. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00538-4 · Cited by 127
A Newly Created Splice Donor Site in Exon 25 of the MyBP-C Gene Is Responsible for Inherited Hypertrophic Cardiomyopathy With Incomplete Disease Penetrance
Moolman, J., Reith, S., Uhl, K., Bailey, S., Gautel, M., Jeschke, B., Fischer, C., Ochs, J., McKenna, W. J., Klues, H., et al. (2000) · Circulation · doi:10.1161/01.cir.101.12.1396 · Cited by 127
Antifibrotic Effects of Antioxidant N-Acetylcysteine in a Mouse Model of Human Hypertrophic Cardiomyopathy Mutation
Marian, A. J., Senthil, V., Chen, S. N., & Lombardi, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.041 · Cited by 126
Self-citation
Hypertrophic cardiomyopathy: from genetics to treatment
Marian, A. J. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02268.x · Cited by 126
Self-citation
Codon 102 of the Cardiac Troponin T Gene Is a Putative Hot Spot for Mutations in Familial Hypertrophic Cardiomyopathy
Forissier, J.-F., Carrier, L., Farza, H., Bonne, G., Bercovici, J., Richard, P., Hainque, B., Townsend, P. J., Yacoub, M. H., Fauré, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.12.3069 · Cited by 122
Toronto Hypertrophic Cardiomyopathy Genotype Score for Prediction of a Positive Genotype in Hypertrophic Cardiomyopathy
Gruner, C., Ivanov, J., Care, M. E., Williams, L. K., Moravsky, G., Yang, H., Laczay, B., Siminovitch, K. A., Woo, A., & Rakowski, H. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.112.963363 · Cited by 122
Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy
Friedrich, F. W., Wilding, B. R., Reischmann, S., Crocini, C., Lang, P. M., Charron, P., Müller, O. J., McGrath, M. J., Vollert, I., Hansen, A., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds157 · Cited by 119
Non‐stop decay—a new mRNA surveillance pathway
Vasudevan, S., Peltz, S. W., & Wilusz, C. J. (2002) · BioEssays · doi:10.1002/bies.10153 · Cited by 117
Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice.
Oberst, L., Zhao, G., Park, J. T., Brugada, R., Michael, L. H., Entman, M. L., Roberts, R., & Marian, A. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4088 · Cited by 116
Self-citation
Multidimensional structure-function relationships in human β-cardiac myosin from population-scale genetic variation
Homburger, J. R., Green, E. M., Caleshu, C. A., Sunitha, M. S., Taylor, R. E., Ruppel, K. M., Metpally, R. P. R., SHaRe Investigators, Colan, S. D., Michels, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606950113 · Cited by 116
Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy
Biagini, E., Spirito, P., Rocchi, G., Ferlito, M., Rosmini, S., Lai, F., Lorenzini, M., Terzi, F., Reggiani, M. L. B., Boriani, G., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.07.057 · Cited by 115
Syncope in hypertrophic cardiomyopathy: Multivariate analysis of prognostic determinants
Nienaber, C. A., Hiller, S., Spielmann, R. P., Geiger, M., & Kück, K. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90222-b · Cited by 113
Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: Mechanisms and therapeutic opportunities
Schlossarek, S., Mearini, G., & Carrier, L. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.01.014 · Cited by 113
A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy
Gilligan, D. M., Chan, W., Joshi, J., Clarke, P., FLETCHER, A. E., Krikler, S. J., & Oakley, C. M. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90386-f · Cited by 112
How do MYBPC3 mutations cause hypertrophic cardiomyopathy?
Marston, S. B., Copeland, O., Gehmlich, K., Schlossarek, S., & Carrrier, L. (2011) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-011-9268-3 · Cited by 112
Strategic Approaches to Unraveling Genetic Causes of Cardiovascular Diseases
Marian, A. J., & Belmont, J. W. (2011) · Circulation Research · doi:10.1161/circresaha.110.236067 · Cited by 109
Self-citation
Clinical and Functional Characterization of TNNT2 Mutations Identified in Patients With Dilated Cardiomyopathy
Hershberger, R. E., Pinto, J. R., Parks, S. B., Kushner, J. D., Li, D., Ludwigsen, S., Cowan, J. R., Morales, A., Parvatiyar, M. S., & Potter, J. D. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.846733 · Cited by 107
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications
Vriesendorp, P. A., Schinkel, A. F. L., Cleemput, J. V., Willems, R., Jordaens, L. J. L. M., Theuns, D. A. M. J., van Slegtenhorst, M. A., de Ravel, T. J. L., ten Cate, F. J., & Michels, M. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.06.009 · Cited by 105
Biallelic Truncating Mutations in ALPK3 Cause Severe Pediatric Cardiomyopathy
Almomani, R., Verhagen, J. M. A., Herkert, J. C., Brosens, E., van Spaendonck‐Zwarts, K. Y., Asimaki, A., van der Zwaag, P. A., Frohn-Mulder, I. M. E., Bertoli‐Avella, A. M., Boven, L. G., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.10.093 · Cited by 105
β Blockers for Prevention of Exercise-Induced Left Ventricular Outflow Tract Obstruction in Patients With Hypertrophic Cardiomyopathy
Nistri, S., Olivotto, I., Maron, M. S., Ferrantini, C., Coppini, R., Grifoni, C., Baldini, K., Sgalambro, A., Cecchi, F., & Maron, B. J. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.051 · Cited by 104
Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy
Witjas‐Paalberends, E. R., Piroddi, N., Stam, K., van Dijk, S. J., Sequeira, V., Ferrara, C., Scellini, B., Hazebroek, M. R., ten Cate, F. J., van Slegtenhorst, M., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt119 · Cited by 103
A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart
Leptidis, S., el Azzouzi, H., Lok, S. I., de Weger, R. A., Olieslagers, S., Kisters, N., da Silva, G. J. J., Heymans, S. R. B., Cuppen, E. P. J. G., Berezikov, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057800 · Cited by 103
Two-dimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: a study in athletes and in patients with hypertrophic cardiomyopathy
Butz, T., van Buuren, F., Mellwig, K., Langer, C., Plehn, G., Meißner, A., Trappe, H., Horstkotte, D., & Faber, L. (2010) · International journal of cardiac imaging · doi:10.1007/s10554-010-9665-5 · Cited by 103
Mutations of the Light Meromyosin Domain of the β-Myosin Heavy Chain Rod in Hypertrophic Cardiomyopathy
Blair, E. M., Redwood, C. S., Oliveira, S. M., Moolman‐Smook, J. C., Brink, P. A., Corfield, V. A., Östman‐Smith, I., & Watkins, H. C. (2002) · Circulation Research · doi:10.1161/hh0302.104532 · Cited by 102
EFFICACY OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS FOR THE PREVENTION OF SUDDEN DEATH IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
Aron, A. J. M., Hen, W., Ink, M., Pstein, E. E., Lmquist, A. D. K. A., Aubert, J.-T., Ardy, G. U. H. B., Avale, S. T. F., R, R. O. F., Oriani, G., et al. (2000) · Cited by 102
Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy
林, 丈. (2004) · Medical Entomology and Zoology · Cited by 102
The current status of myocardial disarray in hypertrophic cardiomyopathy.
Davies, M. J. (1984) · Heart · doi:10.1136/hrt.51.4.361 · Cited by 101
Rescue of cardiomyopathy through U7snRNA‐mediated exon skipping in Mybpc3‐targeted knock‐in mice
Gedicke, C., Behrens‐Gawlik, V., Reischmann, S., Geertz, B., Stimpel, D., Weinberger, F., Schlossarek, S., Précigout, G., Braren, I., Thomas Eschenhagen, A., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202168 · Cited by 101
Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene
Deprez, R. H. L., Muurling-Vlietman, J. J., Hruda, J., Baars, M. J. H., Wijnaendts, L. C. D., Stolte‐Dijkstra, I., Alders, M. M., & van Hagen, J. M. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.040329 · Cited by 101
Sarcomere Mutation-Specific Expression Patterns in Human Hypertrophic Cardiomyopathy
Helms, A. S., Davis, F. M., Coleman, D., Bartolone, S. N., Glazier, A. A., Pagani, F. D., Yob, J. M., Sadayappan, S., Pedersen, E. B., Lyons, R., et al. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.113.000448 · Cited by 101
Role of Candidate Modifier Genes on the Phenotypic Expression of Hypertrophy in Patients with Hypertrophic Cardiomyopathy
Brugada, R., Kelsey, W., Lechin, M. E., Zhao, G., Yu, Q., Zoghbi, W. A., Quinones, M., Elstein, E., Omran, A., Rakowski, H., et al. (1997) · Journal of Investigative Medicine · doi:10.1177/108155899704500910 · Cited by 100
Self-citation
Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy
Derda, A. A., Thum, S., Lorenzen, J. M., Bavendiek, U., Heineke, J., Keyser, B., Stuhrmann, M., Givens, R. C., Kennel, P. J., Schulze, P. C., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.185 · Cited by 100
Molecular genetics and pathogenesis of cardiomyopathy
Kimura, A. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.83 · Cited by 99
Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy
Helms, A. S., Alvarado, F. J., Yob, J. M., Tang, V. T., Pagani, F. D., Russell, M. W. W., Valdivia, H. H., & Day, S. M. (2016) · Circulation · doi:10.1161/circulationaha.115.020086 · Cited by 98
Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy
McGill, L., Ismail, T. F., Nielles‐Vallespin, S., Ferreira, P., Scott, A. D., Roughton, M., Kilner, P. J., Ho, S. Y., McCarthy, K. P., Gatehouse, P. D., et al. (2012) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/1532-429x-14-86 · Cited by 97
Idiopathic myocardial hypertrophy without congestive heart failure or obstruction to blood flow
D, E. B. M., & AYGEN, M. M. (1963) · The American Journal of Medicine · doi:10.1016/0002-9343(63)90159-1 · Cited by 96
Serum Levels of High-Sensitivity Troponin T: A Novel Marker for Cardiac Remodeling in Hypertrophic Cardiomyopathy
Moreno, V., Hernández‐Romero, D., Vilchez, J. A., García‐Honrubia, A., Cambronero, F., Casas, T., González, J. M. R., Martínez, P., Climent, V. E., de la Morena, G., et al. (2010) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2010.07.245 · Cited by 96
Sarcomere Mutations in Cardiomyopathy With Left Ventricular Hypertrabeculation
Dellefave‐Castillo, L. M., Pytel, P., Mewborn, S. K., Mora, B. N., Guris, D. L., Fedson, S., Waggoner, D., Moskowitz, I. P. G., & McNally, E. M. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.861955 · Cited by 95
Familial hypertrophic cardiomyopathy. Microsatellite haplotyping and identification of a hot spot for mutations in the beta-myosin heavy chain gene.
Dausse, E., Michel Komajda, N., Fetler, L., Dubourg, O., Dufour, C., Carrier, L., Wisnewsky, C., Bercovici, J., Hengstenberg, C., & Al‐Mahdawi, S. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116900 · Cited by 90
Inheritance of hypertrophic cardiomyopathy: a cross sectional and M mode echocardiographic study of 50 families.
Greaves, S., Roche, A., Neutze, J. M., Whitlock, R. M. L., & Veale, A. M. O. (1987) · Heart · doi:10.1136/hrt.58.3.259 · Cited by 90
Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy.
Marian, A. J., Yu, Q., Mares, A., Hill, R., Roberts, R., & Perryman, M. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116101 · Cited by 88
Self-citation
Proteins involved in the degradation of cytoplasmic mRNA in the major eukaryotic model systems
Siwaszek, A., Ukleja, M., & Dziembowski, A. (2014) · RNA Biology · doi:10.4161/rna.34406 · Cited by 86
Familial Hypertrophic Cardiomyopathy Mutations from Different Functional Regions of Troponin T Result in Different Effects on the pH and Ca2+ Sensitivity of Cardiac Muscle Contraction
Harada, K., & Potter, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309355200 · Cited by 85
Short Communication: The Cardiac Myosin Binding Protein C Arg502Trp Mutation
Saltzman, A. J., Mancini‐DiNardo, D., Li, C. C., Chung, W. K., Ho, C. Y., Hurst, S., Wynn, J., Care, M. E., Hamilton, R. M., Seidman, G. W., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.216291 · Cited by 75
Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy
Mearini, G., Stimpel, D., Krämer, E., Geertz, B., Braren, I., Gedicke, C., Précigout, G., Müller, O. J., Katus, H. A., Thomas Eschenhagen, A., et al. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2013.31 · Cited by 74
Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice
Barefield, D. Y., Kumar, M., Gorham, J., Seidman, J. G., Seidman, C. E., de Tombe, P. P., & Sadayappan, S. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.11.018 · Cited by 74
A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy
Fujino, N., Shimizu, M., Ino, H., Yamaguchi, M., Yasuda, T., Nagata, M., Konno, T., & Mabuchi, H. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02158-0 · Cited by 72
Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy
Hoskins, A. C., Jacques, A. M., Bardswell, S. C., McKenna, W. J., Tsang, V. T., dos Remedios, C. G., Ehler, E., Adams, K., Jalilzadeh, S., Avkiran, M., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.06.006 · Cited by 71

Research works printed but not linked: 2

10.1161/01.CIR.104.3.317 · DOI
BROCK R. Functional obstruction of the left ventricle (acquired aortic subvalvar stenosis). Guys Hosp Rep. 1959;108:126–143.

Sorted by citations

Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,709
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Olivotto, I., Oreziak, A., Barriales-Villa, R., Abraham, T. P., Masri, A., Garcia-Pavia, P., Saberi, S., Lakdawala, N. K., Wheeler, M. T., Owens, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31792-x · Cited by 1,296
Self-citation
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary
Ommen, S. R., Mital, S. R., Burke, M. A., Day, S. M., Deswal, A. M., Elliot, P. M., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P. F., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 997
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643

See all 1,403

Authors: Marian, A. J., & Braunwald, E.
Affiliations: Brigham and Women's Hospital (US)
From the Center for Cardiovascular Genetics, Institute of Molecular Medicine, Department of Medicine, University of Texas Health Sciences Center at Houston (A.J.M.); Texas Heart Institute, Houston (A.J.M.); and TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (E.B.).
ORCID: Marian, Ali J.
Venue: Circulation Research
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2017-09-15
Volume: 121
Issue: 7
Pages: 749-770
ISSN: 0009-7330 (ISSN-L)
1524-4571
DOI: 10.1161/circresaha.117.311059
PMC: PMC5654557
OpenAlex: W2756203218
Cited by: 1,403
References: 252
Citations by year: 2026: 175 · 2025: 226 · 2024: 219 · 2023: 199 · 2022: 153 · 2021: 174 · 2020: 103 · 2019: 83 · 2018: 61 · 2017: 6
FWCI: 9.75
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Circulation Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL088498, R01HL132401)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: hypertrophic cardiomyopathy, left ventricular hypertrophy, left ventricular outflow tract obstruction, sudden cardiac death, non-sustained ventricular tachycardia, syncope, cardioverter-defibrillator implantation, atrial fibrillation, sarcomere gene mutations, MYH7, MYBPC3, genetic testing, phenocopy, storage diseases, left ventricular diastolic dysfunction, interstitial fibrosis, molecular pathogenesis
MeSH terms: Animals, Biopsy, Cardiomyopathy, Dilated, DNA Mutational Analysis, Genetic Markers, Humans, Mutation, Myocardium, Phenotype, Predictive Value of Tests, Prognosis, Risk Factors, Ventricular Function, Left, Risk Assessment, Genetic Predisposition to Disease, Molecular Diagnostic Techniques, Cardiac Imaging Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks